Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination
NCT01304303
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
57
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor in Advanced Stage
Interventions
DRUG:
SPARC1023 I
DRUG:
SPARC1023 II
Sponsor
Sun Pharma Advanced Research Company Limited